Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Christopher Lowry to Corticotropin-Releasing Hormone

This is a "connection" page, showing publications Christopher Lowry has written about Corticotropin-Releasing Hormone.

 
Connection Strength
 
 
 
3.509
 
  1. Loupy KM, Arnold MR, Hassell JE, Lieb MW, Milton LN, Cler KE, Fox JH, Siebler PH, Schmidt D, Noronha SISR, Day HEW, Lowry CA. Evidence that preimmunization with a heat-killed preparation of Mycobacterium vaccae reduces corticotropin-releasing hormone mRNA expression in the extended amygdala in a fear-potentiated startle paradigm. Brain Behav Immun. 2019 03; 77:127-140.
    View in: PubMed
    Score: 0.621
  2. Lowry CA, Hale MW, Burke KA, Renner KJ, Moore FL. Fluoxetine potentiates the effects of corticotropin-releasing factor on locomotor activity and serotonergic systems in the roughskin newt, Taricha granulosa. Horm Behav. 2009 Jun; 56(1):177-84.
    View in: PubMed
    Score: 0.318
  3. Lowry CA, Hale MW, Plant A, Windle RJ, Shanks N, Wood SA, Ingram CD, Renner KJ, Lightman SL, Summers CH. Fluoxetine inhibits corticotropin-releasing factor (CRF)-induced behavioural responses in rats. Stress. 2009 May; 12(3):225-39.
    View in: PubMed
    Score: 0.318
  4. Evans AK, Heerkens JL, Lowry CA. Acoustic stimulation in vivo and corticotropin-releasing factor in vitro increase tryptophan hydroxylase activity in the rat caudal dorsal raphe nucleus. Neurosci Lett. 2009 May 08; 455(1):36-41.
    View in: PubMed
    Score: 0.315
  5. Spiga F, Lightman SL, Shekhar A, Lowry CA. Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons. Neuroscience. 2006; 138(4):1265-76.
    View in: PubMed
    Score: 0.255
  6. Lowry CA, Moore FL. Regulation of behavioral responses by corticotropin-releasing factor. Gen Comp Endocrinol. 2006 Mar; 146(1):19-27.
    View in: PubMed
    Score: 0.253
  7. Staub DR, Spiga F, Lowry CA. Urocortin 2 increases c-Fos expression in topographically organized subpopulations of serotonergic neurons in the rat dorsal raphe nucleus. Brain Res. 2005 May 24; 1044(2):176-89.
    View in: PubMed
    Score: 0.240
  8. Henry BA, Lightman SL, Lowry CA. Distribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibres. J Neuroendocrinol. 2005 Mar; 17(3):135-44.
    View in: PubMed
    Score: 0.238
  9. Lowry CA, Burke KA, Renner KJ, Moore FL, Orchinik M. Rapid changes in monoamine levels following administration of corticotropin-releasing factor or corticosterone are localized in the dorsomedial hypothalamus. Horm Behav. 2001 May; 39(3):195-205.
    View in: PubMed
    Score: 0.183
  10. Lowry CA, Rodda JE, Lightman SL, Ingram CD. Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system. J Neurosci. 2000 Oct 15; 20(20):7728-36.
    View in: PubMed
    Score: 0.176
  11. Lowry CA, Rose JD, Moore FL. Corticotropin-releasing factor enhances locomotion and medullary neuronal firing in an amphibian. Horm Behav. 1996 Mar; 30(1):50-9.
    View in: PubMed
    Score: 0.128
  12. Lowry CA, Moore FL. Corticotropin-releasing factor (CRF) antagonist suppresses stress-induced locomotor activity in an amphibian. Horm Behav. 1991 Mar; 25(1):84-96.
    View in: PubMed
    Score: 0.090
  13. Lowry CA, Deviche P, Moore FL. Effects of corticotropin-releasing factor (CRF) and opiates on amphibian locomotion. Brain Res. 1990 Apr 09; 513(1):94-100.
    View in: PubMed
    Score: 0.085
  14. Lowry CA, Hale MW, Evans AK, Heerkens J, Staub DR, Gasser PJ, Shekhar A. Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Ann N Y Acad Sci. 2008 Dec; 1148:86-94.
    View in: PubMed
    Score: 0.077
  15. Forster GL, Pringle RB, Mouw NJ, Vuong SM, Watt MJ, Burke AR, Lowry CA, Summers CH, Renner KJ. Corticotropin-releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity. Eur J Neurosci. 2008 Jul; 28(2):299-310.
    View in: PubMed
    Score: 0.075
  16. Staub DR, Evans AK, Lowry CA. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons. Brain Res. 2006 Jan 27; 1070(1):77-89.
    View in: PubMed
    Score: 0.063
  17. Summers CH, Kampshoff JL, Ronan PJ, Lowry CA, Prestbo AA, Korzan WJ, Renner KJ. Monoaminergic activity in subregions of raph? nuclei elicited by prior stress and the neuropeptide corticotropin-releasing factor. J Neuroendocrinol. 2003 Dec; 15(12):1122-33.
    View in: PubMed
    Score: 0.055
  18. Neufeld-Cohen A, Evans AK, Getselter D, Spyroglou A, Hill A, Gil S, Tsoory M, Beuschlein F, Lowry CA, Vale W, Chen A. Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits. Mol Psychiatry. 2010 Apr; 15(4):426-41, 339.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)